Member Info for TradeWizard89

In my opinion maintaining the current BOD gives the company the best chance to execute its long term strategy and realise value without the setbacks that often accompany abrupt leadership change. Not sure this compny can deal with further uncertainty

Continuity is massively important when conducting business is a very specialist field like oncology modelling, thats why current C suite is best position to deliver on long term objectives. A costly board change will only obliterate any progress made towards achieving revenue growth.

Just can’t understand this narrative to change boards when the company is getting its act together, why would that make sense? I doubt plunging the company into further uncertainty through the appointment of a clueless board would help the SP at all…

Jim and Pete did a good presentation - just shows that this is such a technical pitch and you have to know the science behind it.

Now posting AI slop, if your going to make it so blindingly obvious atleast state you are using chatGPT for analysis

I must say LauraI’m impressed by your ability to refresh this chat and avoid any conversation that actually has anything to do with PYC. You would make a good British politician

I don’t think Laura and co have thought through what will happen with a full replacement BoD, blinded by their clear agenda.

Funny how any comment you dislike seems to magically disappear

I mean KMK still up 86% on the year so im not sure Tuan6 is losing? The whole market is gloomy right now so its hard to point fingers at KMK.

Ummm, whats worse is the costly process of appointing a new board of journeymen which would ultimately disrupt any positive movement this business is going to have in the near future.

SpectralBlue - seems like you have stirred the hornets nest. Doesn't take a brainbox to understand the high costs of a new board packed with journeymen, especially during a period where the company is looking up. Admittedly I'm not a long term investor of PYC therefore do not share a lot of the sentiment of this forum. But looking from an almost neutral perspective it doesn't make much sense to make said changes at such a period in time.

Highly doubt a change in board will do anything good for the company, specially in a period of turbulent waters.

Iknownuffin, Cant really take this article at face value when we know that Alan Green (who runs this website) is in cahoots with Doc H who is trying to take over Physiomics

Some good insight Stuartrm. KMK down in the last month but so is 90% of my portfolio, KMK one of the more resilient stocks i hold which is welcomed.

Hoping to come good on this stock and which i do believe will happen sooner rather than later. Especially with the increased focus on core competencies i think BATM is now on the right track for significant growth.

Topping up certainly, slightly annoyed as thought 12p was the new floor however current climate affecting most my portfolio. Will bounce back shortly no doubt!

Well that is good news and reaffirms my confidence that KMK can now build off of a clean sheet. A target of 19p seems steep but definitely doable given the last bullish run from the 6p mark.

Definitely feel comfortable buying in around the 12p mark now there seems to more stability. Interested to see what happens over the next half year.

Good point you make there Spectral. We have seen the price dip despite good news in the past. Hopefully can hold here as a new floor to build upon when more good news comes in the future!

Excited to see where KMK will be come year end. Now has some strong fundamentals to build off and hopefully secure long term profitability.